These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 11210403

  • 1. Lack of interaction between levofloxacin and oxycodone: pharmacokinetics and drug disposition.
    Grant EM, Zhong M, Fitzgerald JF, Nicolau DP, Nightingale C, Quintiliani R.
    J Clin Pharmacol; 2001 Feb; 41(2):206-9. PubMed ID: 11210403
    [Abstract] [Full Text] [Related]

  • 2. Minimal interaction between gatifloxacin and oxycodone.
    Grant EM, Nicolau DR, Nightingale C, Quintiliani R.
    J Clin Pharmacol; 2002 Aug; 42(8):928-32. PubMed ID: 12162476
    [Abstract] [Full Text] [Related]

  • 3. Effects of food and sucralfate on a single oral dose of 500 milligrams of levofloxacin in healthy subjects.
    Lee LJ, Hafkin B, Lee ID, Hoh J, Dix R.
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2196-200. PubMed ID: 9333047
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics and pharmacodynamics of intravenous levofloxacin in patients with early-onset ventilator-associated pneumonia.
    Pea F, Di Qual E, Cusenza A, Brollo L, Baldassarre M, Furlanut M.
    Clin Pharmacokinet; 2003 Oct; 42(6):589-98. PubMed ID: 12793843
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparative bactericidal activities of ciprofloxacin, clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Streptococcus pneumoniae in a dynamic in vitro model.
    Klepser ME, Ernst EJ, Petzold CR, Rhomberg P, Doern GV.
    Antimicrob Agents Chemother; 2001 Mar; 45(3):673-8. PubMed ID: 11181341
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of levofloxacin in healthy Thai male volunteers.
    Chulavatnatol S, Chindavijak B, Vibhagool A, Wananukul W, Sriapha C, Sirisangtragul C.
    J Med Assoc Thai; 1999 Nov; 82(11):1127-35. PubMed ID: 10659548
    [Abstract] [Full Text] [Related]

  • 11. A randomized, crossover design study of the pharmacology of extended-spectrum fluoroquinolones for pneumococcal infections.
    Amsden GW, Graci DM, Cabelus LJ, Hejmanowski LG.
    Chest; 1999 Jul; 116(1):115-9. PubMed ID: 10424513
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. An in vivo study comparing the ocular absorption of levofloxacin and ciprofloxacin prior to phacoemulsification.
    Bucci FA.
    Am J Ophthalmol; 2004 Feb; 137(2):308-12. PubMed ID: 14962422
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose.
    Wagenlehner FM, Kinzig-Schippers M, Tischmeyer U, Wagenlehner C, Sörgel F, Dalhoff A, Naber KG.
    Int J Antimicrob Agents; 2006 Jan; 27(1):7-14. PubMed ID: 16343856
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended release formulation of oxycodone with sequestered naltrexone.
    Gandelman K, Lamson M, Salageanu J, Bramson C, Matschke K, Malhotra B.
    Clin Pharmacol Drug Dev; 2015 Sep; 4(5):370-6. PubMed ID: 27137146
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Absence of a pharmacokinetic interaction between intravenous theophylline and orally administered levofloxacin.
    Gisclon LG, Curtin CR, Fowler CL, Williams RR, Hafkin B, Natarajan J.
    J Clin Pharmacol; 1997 Aug; 37(8):744-50. PubMed ID: 9378847
    [Abstract] [Full Text] [Related]

  • 20. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
    Odenholt I, Cars O.
    J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.